Our results indicate the potential role of lncRNA GAS5 polymorphisms rs2067079 and rs6790 as predictive biomarkers for chemoradiotherapy induced toxic reactions in NPC patients. This evidence concerns the gene GAS5 and nasopharyngeal carcinoma.